1196186

CMP Pharma Inc — FEI 1050589

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 25, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Farmville, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)